DexCom Equity Securities Without Readily Determinable Fair Value - Cumulative Downward Adjustments increased by 0.7% to $219.50M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase suggests declining value or impairment in the bank's private equity or strategic investment portfolio.
This metric represents the cumulative impairment losses recognized on equity investments that lack a readily determinabl...
Commonly reported by large financial institutions with significant venture capital or strategic investment arms.
equity_securities_no_fv_downward_adj| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $218.00M | $219.50M |
| QoQ Change | — | +0.7% |